Aim & Scope
Clinical Cardiovascular Research (ISSN: 2836-5917) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Clinical Cardiovascular Research (ISSN: 2836-5917) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Clinical Cardiovascular Research (ISSN: 2836-5917) is an Open Access single blinded peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Clinical Cardiovascular Research (ISSN: 2836-5917) deals with the disorders and complications that are related to heart, blood vessels, and circulatory system, heart failure, hypertension, arrhythmias, and advances in diagnosis and therapy.
The current research in Clinical Cardiovascular Research (ISSN: 2836-5917) involves in the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners and even for common people.
Clinical Cardiovascular Research (ISSN: 2836-5917) accepts the articles in the fields of: Cardiovascular Diseases (CVD), Heart Disease, Atherosclerosis, Hypertension, Myocardial Infarction, Stroke, Heart Failure, Arrhythmias, Coronary Artery Disease (CAD), Echocardiography, Electrocardiogram (ECG/EKG), Cardiac Biomarkers, Lipid Profile, Cardiovascular Risk Factors, Cardiac Rehabilitation, Exercise Physiology in Cardiology, Cardiac Catheterization, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG), Valve Replacement Surgery, Stent Placement, Endovascular Repair, Transcatheter Aortic Valve Replacement (TAVR), Antiplatelet Therapy, Beta-Blockers, ACE Inhibitors, Statins & Lipid-Lowering Drugs, Anticoagulation Therapy, Novel Cardiovascular Drugs, Diabetes & Cardiovascular Disease, Obesity & Heart Disease, Metabolic Syndrome, Inflammatory Markers (CRP, IL-6), Genetic Risk Factors, Cardiac MRI, Coronary Angiography, Computed Tomography Angiography (CTA), Stress Testing, Holter Monitoring, Atrial Fibrillation (AFib).
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
Cardiovascular Diseases (CVD): A group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. CVDs are primarily caused by atherosclerosis, lifestyle factors, and genetic predisposition, leading to impaired blood flow and increased risk of heart-related complications.
Heart Disease: Heart disease refers to a group of conditions that affect the structure and function of the heart, including coronary artery disease, heart failure, and arrhythmias. It often results from blocked blood flow, weakened heart muscles, or abnormal heart rhythms, leading to reduced oxygen supply to the body.
Atherosclerosis: Atherosclerosis is a chronic condition characterized by the buildup of fatty deposits (plaques) along the inner walls of arteries, leading to narrowing and hardening of the vessels. This impairs blood flow and increases the risk of cardiovascular events such as heart attack and stroke.
Hypertension: Hypertension is a chronic medical condition characterized by consistently elevated blood pressure in the arteries, typically defined as a systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg. It increases the risk of heart disease, stroke, and kidney damage.
Myocardial Infarction: Myocardial Infarction (MI) is the necrosis of heart muscle tissue due to a sudden interruption of blood supply, usually from a blockage in a coronary artery. It often presents with chest pain, shortness of breath, and may lead to life-threatening complications if untreated.
Stroke: Stroke is the sudden damage or death of heart muscle tissue due to a blockage in the coronary arteries that restricts blood flow. It typically results in chest pain, shortness of breath, and may lead to life-threatening complications if not treated promptly.
Heart Failure: A clinical syndrome in which the heart is unable to pump sufficient blood to meet the body’s metabolic demands, leading to symptoms such as shortness of breath, fatigue, and fluid retention. It can result from structural or functional cardiac abnormalities affecting the heart’s ability to fill or eject blood effectively.
Arrhythmias: Arrhythmias are abnormal heart rhythms resulting from irregularities in the heart’s electrical conduction system. They can cause the heart to beat too fast, too slow, or irregularly, potentially leading to symptoms like palpitations, dizziness, or fainting.
Coronary Artery Disease (CAD): Coronary Artery Disease (CAD) is a condition characterized by the narrowing or blockage of the coronary arteries due to atherosclerosis, which reduces blood flow to the heart muscle. This can lead to chest pain (angina), heart attacks, and other cardiovascular complications.
Echocardiography: Echocardiography is a non-invasive diagnostic technique that uses ultrasound waves to create real-time images of the heart. It assesses cardiac structure, function, and blood flow, aiding in the diagnosis of heart diseases and monitoring treatment outcomes.
